Brainsway announces preliminary results from Accelerated Deep TMS study

BrainsWay (BWAY) announced preliminary results from a multicenter, randomized controlled trial titled, “Accelerated Deep TMS for Depression: Results from a Multisite, Randomized Non-Inferiority Trial.” The results suggest that the accelerated Deep Transcranial Magnetic Stimulation, Deep TMS, protocol using intermittent theta burst stimulation, iTBS, to treat patients with major depressive disorder, MDD, resulted in outcomes that are comparable to the standard once-daily TMS protocol – while requiring considerably fewer visits to the clinic. The accelerated Deep TMS group achieved significant improvement that was comparable to the standard Deep TMS group; Accelerated Deep TMS sessions lasted less than 10 minutes, compared to 20 minutes for standard treatment sessions; Median time to remission was 21 days for the accelerated group v. 28 days for the standard group; The accelerated protocol was well-tolerated, with no reported serious adverse events; The study was conducted using BrainsWay’s H1 Coil with standard targeting, without reliance on any neuronavigation equipment